<?xml version="1.0" encoding="UTF-8"?>
<p>FDA-approved drugs and agents re-purposed for COVID-19, such as ribavirin, IFNs and corticosteroids, were shown, however, to be ineffective especially in severe CoV infections (
 <xref rid="b48-ijmm-46-02-0489" ref-type="bibr">48</xref>); recent data on SARS-CoV2 suggest that more specific and efficacious treatments can be administered to COVID-19 patients; 
 <xref rid="tII-ijmm-46-02-0489" ref-type="table">Table II</xref> summarizes such proposed FDA-approved drugs and 
 <xref rid="f3-ijmm-46-02-0489" ref-type="fig">Fig. 3</xref> offers a graphic presentation.
</p>
